Martin Köberle

7PUBLICATIONS
14CO-AUTHORS
Molecular medicineFood properties (incl. characteristics and health benefits)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Veterinary epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 10, 2026
Modulation of Mast Cell Activation via MRGPRX2 by Natural Oat Extract.

Susanne Kaesler, Désirée Argiriu, Shyami M Kandage

|Aug 29, 2024
Vitamin C-Dependent Uptake of Non-Heme Iron by Enterocytes, Its Impact on Erythropoiesis and Redox Capacity of Human Erythrocytes.

Xia Pan, Martin Köberle, Mehrdad Ghashghaeinia

|Mar 25, 2022
Fetal Tissue-Derived Mast Cells (MC) as Experimental Surrogate for In Vivo Connective Tissue MC.

Caterina Iuliano, Magdalena Absmaier-Kijak, Tobias Sinnberg

|Dec 11, 2020
Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication.

Mehrdad Ghashghaeinia, Peter Dreischer, Thomas Wieder

|Oct 16, 2020
Googling for Ticks and Borreliosis in Germany: Nationwide Google Search Analysis From 2015 to 2018.

Cora Scheerer, Melvin Rüth, Linda Tizek

|Jul 09, 2020
The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis.

Mehrdad Ghashghaeinia, Pavla Koralkova, Daniela Giustarini

Pageof 2